Compounds > econazole

econazole and isoniazid

econazole has been researched along with isoniazid in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Botta, M; Castagnolo, D; De Logu, A; Dessì, F; Manetti, F; Meleddu, R; Radi, M; Saddi, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Baralle, M; De Logu, A; Mamolo, MG; Pau, V; Romano, M; Skoko, N; Vio, L; Zampieri, D1
Besra, GS; Burguière, A; Dell, A; Dover, LG; Hitchen, PG1
Ahmad, Z; Khuller, GK; Sharma, S1

Other Studies

7 other study(ies) available for econazole and isoniazid

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis.
    Bioorganic & medicinal chemistry letters, 2009, Apr-15, Volume: 19, Issue:8

    Topics: Antitubercular Agents; Azoles; Drug Evaluation, Preclinical; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Stereoisomerism

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Antimycobacterial activity of new N(1)-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives.
    Bioorganic & medicinal chemistry letters, 2016, 07-15, Volume: 26, Issue:14

    Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Dose-Response Relationship, Drug; Fungi; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Pyridines; Structure-Activity Relationship

2016
Altered expression profile of mycobacterial surface glycopeptidolipids following treatment with the antifungal azole inhibitors econazole and clotrimazole.
    Microbiology (Reading, England), 2005, Volume: 151, Issue:Pt 6

    Topics: Antitubercular Agents; Cell Wall; Clotrimazole; Econazole; Ethionamide; Glycolipids; Glycopeptides; Isoniazid; Molecular Structure; Mycobacterium; Mycobacterium avium; Mycobacterium smegmatis

2005
In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H37Rv.
    FEMS microbiology letters, 2005, Oct-01, Volume: 251, Issue:1

    Topics: Anti-Bacterial Agents; Clotrimazole; Colony Count, Microbial; Drug Synergism; Econazole; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin

2005